A Study to Evaluate the Use of Nitazoxanide to Treat Cryptosporidiosis

NCT00002158 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2007-07-10

No results posted yet for this study

Summary

The purpose of this study is to see if nitazoxanide (NTZ) can be used to treat AIDS patients suffering from cryptosporidiosis (diarrhea caused by the parasite Cryptosporidium).

Conditions

  • Cryptosporidiosis
  • HIV Infections

Interventions

DRUG

Nitazoxanide

Sponsors & Collaborators

  • Romark Laboratories L.C.

    lead INDUSTRY

Study Design

Purpose
TREATMENT

Eligibility

Min Age
3 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00002158 on ClinicalTrials.gov